Joint Md

HDFC Bank a must in core portfolio; Tata Motors value buy: Pros

HDFC Bank remains a stock that should be in every investor's core portfolio, said Dilip Bhat, Prabhudas Lilladher.

See pre-Budget rally; hoping Budget addresses woes: Dilip Bhat

Speaking to CNBC-TV18 Dilip Bhat, Joint MD, Prabhudas Lilladher said that he expects some kind of a pre-Budget rally. This rally will largely pin its hopes on PM assuaging sentiments in terms of taxes. â€œI think a talk on those lines will help sentiments."

Demonetisation impact: GST uncertainty bigger worry for consumer durables, say experts

Not at all worried about the demonetisation impact and believes the industry has the potential to grow by 15% in the calendar-year 2017, said B Thiagarajan, Joint MD, Blue Star.

Dilip Bhat picks ACC & Aurobindo; says Nifty won't go below 8000

The level of 8000 on the Nifty is a very strong support and it is unlikely that it will go below that, says Dilip Bhat, Joint MD, Prabhudas Lilladher.

Shasun Pharma, SeQuent in animal health products JV

SeQuent Scientific will hold 73 percent in the joint venture, while Shasun will own the remaining 27 percent and both will contribute by way of transfer of identified assets, contracts and licenses.

Bajaj Electricals Q4 net down 99%; eyes 20% sales growth

Bajaj Electricals' Q4 net declined almost two-fold to Rs 0.62 crore as it restructured its engineering and projects business amid sluggish growth in the sector.

Jyothy Labs expects 25% sales growth in FY14

Soaps and detergent maker Jyothy Laboratories expects its topline to rise 25 percent year-on-year in FY2014, as it expands into new geographies and products, Ullas Kamath, Joint MD, said on Friday.

BHEL continue to remain sideways, says Dilip Bhat

BHEL continue to remain sideways, says Dilip Bhat, Joint MD, Prabhudas Lilladher.

PNB a good investment bet, says Dilip Bhat

PNB is a good investment bet, says Dilip Bhat, Joint MD, Prabhudas Lilladher.

Amisha Vora remains bullish on Maruti Suzuki

Amisha Vora, Joint MD, Prabhudas Lilladher remains bullish on Maruti Suzuki.

United Phosphorous may give 35% returns: Vora

United Phosphorous may give 35% returns, says Amisha Vora, Joint MD, Prabhudas Lilladher.

Maruti Suzuki can move to Rs 1700: Dilip Bhat

Maruti Suzuki can move to Rs 1700 over next 8-10 months, says Dilip Bhat, Joint MD, Prabhudas Lilladher.

Wipro can give 18-20% returns, says Dilip Bhat

Wipro can give 18-20% returns in next 12-15 months, says Dilip Bhat, Joint MD, Prabhudas Lilladher.

ITC a good defensive bet: Dilip Bhat

ITC a good defensive bet says Dilip Bhat, Joint MD, Prabhudas Lilladher.

Reliance Industries may rally to Rs 950-960, says Bhat

Reliance Industries may rally to Rs 950-960, says Dilip Bhat, Joint MD, Prabhudas Lilladher.

IOC, BPCL look interesting: Dilip Bhat

In the longer run, Indian Oil Corporation (IOC) and Bharat Petroleum Corporation Limited (BPCL) looks very interesting, says Dilip Bhat, Joint MD, Prabhudas Lilladher.

Tata Motors has potential to test Rs 320- 325: Amisha Vora

Tata Motors has potential to test Rs 320- 325, says Amisha Vora, Joint MD, Prabhudas Lilladher.

Amisha Vora positive on PSU banks

Amisha Vora, Joint MD, Prabhudas Lilladher is positive on PSU banking space.

Bajaj Electricals sees pickup in E&P business from FY14

Bajaj Electricals expects a pickup in engineering and products business, which has been hit by the overall slowdown in infrastructure spending, beginning next financial year, following a clean up of its existing orders, which have seen a significant cost over runs, joint MD Anant Bajaj told moneycontrol.com on Thursday.